| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-010384 |
| cik | 1506983 |
| name | GLUCOTRACK, INC. |
| sic | 3841 |
| countryba | US |
| stprba | NJ |
| cityba | RUTHERFORD |
| zipba | 07070 |
| bas1 | 301 RT 17 NORTH |
| bas2 | SUITE 800 |
| baph | 972 (8) 675-7878 |
| countryma | US |
| stprma | NJ |
| cityma | RUTHERFORD |
| zipma | 07070 |
| mas1 | 301 RT 17 NORTH |
| mas2 | SUITE 800 |
| countryinc | US |
| stprinc | DE |
| ein | 980668934 |
| former | GLUCOTRACK, INC. |
| changed | 20220328 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250514 |
| accepted | 2025-05-14 17:20:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-010384 | 20241231 | Accounts Payable Current | 992000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Adjustments To Additional Paid In Capital Stock Split | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20241231 | Cash And Cash Equivalents At Carrying Value | 5617000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Convertible Notes Payable Current | 9000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Earnings Per Share Basic | -11.7300 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 6000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Increase Decrease In Accounts Payable | 175000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Increase Decrease In Other Current Assets | 64000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Increase Decrease In Other Current Liabilities | -229000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Interest Paid Net | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Issuance Of Restricted Shares As Compensation To Board Of Directors | 78000.0000 | USD | 1 | 0001641172-25-010384 | |||
| 0001641172-25-010384 | 20250331 | Issuance Of Restricted Shares As Compensation To Board Of Directors | USD | 1 | 0001641172-25-010384 | ||||
| 0001641172-25-010384 | 20241231 | Liabilities | 18932000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Liabilities | 2354000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Liabilities And Stockholders Equity | 5932000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Linkage Difference On Principal Of Loans From Stockholders | USD | 1 | 0001641172-25-010384 | ||||
| 0001641172-25-010384 | 20240331 | Net Cash Provided By Used In Investing Activities | -59000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Net Cash Provided By Used In Operating Activities | -2939000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | |||
| 0001641172-25-010384 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 6000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | |||
| 0001641172-25-010384 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 36000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010384 | 20250331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20250331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20241231 | Other Liabilities Current | 252000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Property Plant And Equipment Net | 95000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Selling And Marketing Expense | 70000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20231231 | Stockholders Equity | 48000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | ||
| 0001641172-25-010384 | 20240331 | Stockholders Equity | 22000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010384 | 20241231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20250331 | Stockholders Equity | 28000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010384 | 20250331 | Stockholders Equity | 146259000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20220930 | Stock Issued During Period Shares New Issues | 10000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Type Of Arrangement= Intellectual Property Purchase Agreement; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Exerciseof Prefunded Warrants Into Shares | USD | 1 | 0001641172-25-010384 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Exercise Of Warrants Into Common Stock | USD | 1 | 0001641172-25-010384 | Equity Components= Receipts On Account Of Shares; | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value New Issues | 6394000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value New Issues | 6379000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Payment For Achievement Of Milestone | USD | 1 | 0001641172-25-010384 | ||||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Payment For Achievement Of Milestone | -1000.0000 | USD | 1 | 0001641172-25-010384 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Share Based Compensation | 40000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Stock To Be Issued During Period Value Restricted Stock Award Gross | 78000.0000 | USD | 1 | 0001641172-25-010384 | |||
| 0001641172-25-010384 | 20240331 | Stock To Be Issued During Period Value Restricted Stock Award Gross | USD | 1 | 0001641172-25-010384 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20241231 | Additional Paid In Capital Common Stock | 119229000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Common Stock Shares Issued | 791609.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Common Stock Value | 26000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 36000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Net Cash Provided By Used In Financing Activities | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010384 | 20250331 | Net Proceeds Received From Underwritten Public Offering | 6395000.0000 | USD | 1 | 0001641172-25-010384 | |||
| 0001641172-25-010384 | 20241231 | Other Assets Current | 151000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 6000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Receipts On Account Of Shares | 228000.0000 | USD | 0 | 0001641172-25-010384 | |||
| 0001641172-25-010384 | 20250331 | Stockholders Equity | 7258000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Stock Issued During Period Shares New Issues | 501507.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series A Warrants; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Exerciseof Prefunded Warrants Into Shares | USD | 1 | 0001641172-25-010384 | ||||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Exerciseof Prefunded Warrants Into Shares | -2000.0000 | USD | 1 | 0001641172-25-010384 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Exercise Of Warrants Into Common Stock | 20620000.0000 | USD | 1 | 0001641172-25-010384 | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value New Issues | 15000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Share Based Compensation | 22000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Share Based Compensation | 22000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Share Based Compensation | 40000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 28000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Adjustments To Additional Paid In Capital Stock Split Shares | 54512.0000 | shares | 1 | 0001641172-25-010384 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20250331 | Assets | 9612000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Common Stock Shares Outstanding | 25585853.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Comprehensive Income Net Of Tax | -2921000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Convertible Notes Payable Current | 5000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241031 | Derivative Liabilities Noncurrent | 16626000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Increase Decrease In Accounts Payable | 620000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Payments To Acquire Property Plant And Equipment | 59000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Receipts On Account Of Shares | 228000.0000 | USD | 0 | 0001641172-25-010384 | |||
| 0001641172-25-010384 | 20250331 | Increase Decrease In Other Current Assets | 204000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Liabilities Current | 1275000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Linkage Difference On Principal Of Loans From Stockholders | -1000.0000 | USD | 1 | 0001641172-25-010384 | |||
| 0001641172-25-010384 | 20240331 | Net Income Loss | -2927000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010384 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010384 | 20250331 | Operating Lease Liability Current | 26000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010384 | 20240331 | Share Based Compensation | 22000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Shares Outstanding | 791609.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20241231 | Stockholders Equity | 228000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Shares Exerciseof Prefunded Warrants Into Shares | 19765.0000 | USD | 1 | 0001641172-25-010384 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Shares Exercise Of Warrants Into Common Stock | 9723723.0000 | shares | 1 | 0001641172-25-010384 | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Shares New Issues | 646.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series B Warrants; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Exerciseof Prefunded Warrants Into Shares | USD | 1 | 0001641172-25-010384 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Exercise Of Warrants Into Common Stock | 20610000.0000 | USD | 1 | 0001641172-25-010384 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Exercise Of Warrants Into Common Stock | 10000.0000 | USD | 1 | 0001641172-25-010384 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | |||
| 0001641172-25-010384 | 20250331 | Amortization Of Financing Costs And Discounts | 3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 3483000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Common Stock Shares Authorized | 250000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Derivative Gain Loss On Derivative Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010384 | 20250331 | Derivative Liabilities Noncurrent | 177000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Net Proceeds Received From Underwritten Public Offering | USD | 1 | 0001641172-25-010384 | ||||
| 0001641172-25-010384 | 20250331 | Earnings Per Share Basic | -0.6700 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Interest Paid Net | 28000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Net Cash Provided By Used In Financing Activities | 6395000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Operating Income Loss | -2951000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Operating Lease Liability Current | 26000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Operating Lease Liability Noncurrent | 33000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Operating Lease Liability Noncurrent | 26000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 36000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20250331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | |||
| 0001641172-25-010384 | 20240331 | Research And Development Expense | 2148000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Research And Development Expense | 1871000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Restricted Cash Noncurrent | 10000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Selling And Marketing Expense | 128000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Share Based Compensation | 192000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20250331 | Shares Outstanding | 25585853.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20241231 | Stockholders Equity | -8000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010384 | 20220930 | Stock Issued During Period Shares New Issues | 10000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Range= Minimum; Type Of Arrangement= Intellectual Property Purchase Agreement; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | -4000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Exerciseof Prefunded Warrants Into Shares | USD | 1 | 0001641172-25-010384 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Exerciseof Prefunded Warrants Into Shares | USD | 1 | 0001641172-25-010384 | Equity Components= Receipts On Account Of Shares; | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Exercise Of Warrants Into Common Stock | USD | 1 | 0001641172-25-010384 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20240331 | Stock To Be Issued During Period Value Restricted Stock Award Gross | USD | 1 | 0001641172-25-010384 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20240331 | Stock To Be Issued During Period Value Restricted Stock Award Gross | USD | 1 | 0001641172-25-010384 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010384 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 249598.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 249598.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -8000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 4502000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 5627000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 9110000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Derivative Gain Loss On Derivative Net | -3376000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Earnings Per Share Diluted | -11.7300 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Long Term Loans Payable | 201000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010384 | 20250331 | Operating Expenses | 3498000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Operating Income Loss | -3498000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 6000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010384 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 36000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010384 | 20250331 | Other Liabilities Current | 303000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Other Nonoperating Income Expense | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010384 | 20250331 | Payments To Acquire Property Plant And Equipment | 9000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20231231 | Stockholders Equity | -109853000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010384 | 20240331 | Stockholders Equity | 376000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Stockholders Equity | 113029000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20241231 | Stockholders Equity | 119229000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20241031 | Stock Issued During Period Shares New Issues | 501507.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series A Warrants; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 1945.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -48000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Payment For Achievement Of Milestone | USD | 1 | 0001641172-25-010384 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | |||
| 0001641172-25-010384 | 20250331 | Adjustments To Additional Paid In Capital Stock Split | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20241231 | Assets Current | 5768000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Assets Current | 9455000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -2995000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Common Stock Shares Outstanding | 791609.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Derivative Liabilities Noncurrent | 17421000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Finance Expense Income Net | 37000.0000 | USD | 1 | 0001641172-25-010384 | |||
| 0001641172-25-010384 | 20240331 | General And Administrative Expense | 733000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Long Term Loans Payable | 203000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Net Income Loss | -2927000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Net Income Loss | -6833000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20241231 | Operating Lease Right Of Use Asset | 59000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Other Assets Current | 355000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Other Nonoperating Income Expense | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Retained Earnings Accumulated Deficit | -132450000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Retained Earnings Accumulated Deficit | -139283000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 79000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010384 | 20250331 | Share Based Compensation | 40000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20231231 | Stockholders Equity | 3197000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Shares Exercise Of Warrants Into Common Stock | 9723723.0000 | shares | 1 | 0001641172-25-010384 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Exercise Of Warrants Into Common Stock | USD | 1 | 0001641172-25-010384 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 10160725.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 10160725.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Additional Paid In Capital Common Stock | 146259000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Adjustments To Additional Paid In Capital Stock Split | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 1507000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250131 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Common Stock Shares Issued | 25585853.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Comprehensive Income Net Of Tax | -6797000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Depreciation And Amortization | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Depreciation And Amortization | 8000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Increase Decrease In Other Current Liabilities | 51000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Liabilities And Stockholders Equity | 9612000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Net Cash Provided By Used In Operating Activities | -2942000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20250331 | Operating Lease Right Of Use Asset | 53000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Restricted Cash Noncurrent | 10000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20231231 | Shares Outstanding | 208914.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20240331 | Shares Outstanding | 267564.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | Represents amount lower than $1. | ||
| 0001641172-25-010384 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20240331 | Stockholders Equity | 78000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | ||
| 0001641172-25-010384 | 20240331 | Stockholders Equity | -112780000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010384 | 20250331 | Stockholders Equity | 26000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20250331 | Stockholders Equity | 228000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Shares Conversion Of Convertible Securities | 35932.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20241031 | Stock Issued During Period Shares New Issues | 501507.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series B Warrants; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Shares Restricted Stock Payment For Achievement Of Milestone | 1000.0000 | shares | 1 | 0001641172-25-010384 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 48000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Payment For Achievement Of Milestone | USD | 1 | 0001641172-25-010384 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Payment For Achievement Of Milestone | USD | 1 | 0001641172-25-010384 | Equity Components= Receipts On Account Of Shares; | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20240331 | Stock To Be Issued During Period Value Restricted Stock Award Gross | 78000.0000 | USD | 1 | 0001641172-25-010384 | Equity Components= Receipts On Account Of Shares; | ||
| 0001641172-25-010384 | 20240331 | Stock To Be Issued During Period Value Restricted Stock Award Gross | USD | 1 | 0001641172-25-010384 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20250331 | Accounts Payable Current | 1612000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Adjustments To Additional Paid In Capital Stock Split | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010384 | 20250331 | Adjustments To Additional Paid In Capital Stock Split | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010384 | 20240331 | Amortization Of Financing Costs And Discounts | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010384 | 20241231 | Assets | 5932000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Cash And Cash Equivalents At Carrying Value | 9100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Earnings Per Share Diluted | -0.6700 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Finance Expense Income Net | 24000.0000 | USD | 1 | 0001641172-25-010384 | |||
| 0001641172-25-010384 | 20250331 | General And Administrative Expense | 1499000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Liabilities Current | 1950000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20250331 | Net Cash Provided By Used In Investing Activities | -9000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010384 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Receipts On Account Of Shares; | |||
| 0001641172-25-010384 | 20250331 | Net Income Loss | -6833000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010384 | 20240331 | Operating Expenses | 2951000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20240331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010384 | 20250331 | Property Plant And Equipment Net | 94000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20231231 | Stockholders Equity | 16000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010384 | 20231231 | Stockholders Equity | 112986000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010384 | 20241231 | Stockholders Equity | -13000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010384 | 20241231 | Stockholders Equity | -132450000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010384 | 20250331 | Stockholders Equity | -139283000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Shares New Issues | 3241886.0000 | shares | 0 | us-gaap/2024 | Equity Components= Series A Warrants; | ||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Shares New Issues | 15016009.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010384 | 20240331 | Stock Issued During Period Value Restricted Stock Payment For Achievement Of Milestone | USD | 1 | 0001641172-25-010384 | Equity Components= Common Stock; | |||
| 0001641172-25-010384 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. |
| Adjustments To Additional Paid In Capital Stock Split | us-gaap/2024 | 0 | 0 | monetary | D | D | Adjustments to Additional Paid in Capital, Stock Split | Amount of decrease in additional paid in capital (APIC) resulting from a stock split in which per-share par value or stated value is not changed proportionately. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Long Term Loans Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Loans Payable, Noncurrent | Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Convertible Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Convertible Notes Payable, Current | Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Derivative Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Derivative Liability, Noncurrent | Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. |
| Adjustments To Additional Paid In Capital Stock Split Shares | 0001641172-25-010384 | 1 | 0 | shares | D | Stock split adjustment, shares | Adjustments to additional paid in capital stock split shares. | |
| Stock Issued During Period Shares Exercise Of Warrants Into Common Stock | 0001641172-25-010384 | 1 | 0 | shares | D | Cashless exercise of warrants into common stock,shares | Stock issued during period shares exercise of warrants into common stock. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Selling And Marketing Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
| Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | |
| Linkage Difference On Principal Of Loans From Stockholders | 0001641172-25-010384 | 1 | 0 | monetary | D | D | Linkage difference on principal of loans from stockholders | Linkage difference on principal of loans from stockholders . |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. | |
| Issuance Of Restricted Shares As Compensation To Board Of Directors | 0001641172-25-010384 | 1 | 0 | monetary | D | D | IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors | Issuance of restricted shares as compensation to the board of directors. |
| Stock Issued During Period Shares Restricted Stock Payment For Achievement Of Milestone | 0001641172-25-010384 | 1 | 0 | shares | D | Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 5B), shares | Stock issued during period shares restricted stock payment for achievement of milestone. | |
| Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Amortization Of Financing Costs And Discounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs and Discounts | Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Other Current Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Current Liabilities | Amount of increase (decrease) in current liabilities classified as other. |
| Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). |
| Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Current | Amount of current assets classified as other. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Finance Expense Income Net | 0001641172-25-010384 | 1 | 0 | monetary | D | C | FinanceExpenseIncomeNet | Finance expense income net. |
| Stock To Be Issued During Period Value Restricted Stock Award Gross | 0001641172-25-010384 | 1 | 0 | monetary | D | C | Restricted shares to be issued as compensation towards directors | Stock to be issued during period value restricted stock award gross. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Increase Decrease In Other Current Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Current Assets | Amount of increase (decrease) in current assets classified as other. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Net Proceeds Received From Underwritten Public Offering | 0001641172-25-010384 | 1 | 0 | monetary | D | D | Net proceeds from underwritten U.S. public offerings (Note 3A) | Net proceeds received from underwritten public offering. |
| Receipts On Account Of Shares | 0001641172-25-010384 | 1 | 0 | monetary | I | C | Receipts on account of shares | Receipts on account of shares. |
| Stock Issued During Period Value Exercise Of Warrants Into Common Stock | 0001641172-25-010384 | 1 | 0 | monetary | D | C | Cashless exercise of warrants into common stock | Stock issued during period value exercise of warrants into common stock. |
| Stock Issued During Period Value Restricted Stock Payment For Achievement Of Milestone | 0001641172-25-010384 | 1 | 0 | monetary | D | C | Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 4B) | Stock issued during period value restricted stock payment for achievement of milestone. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Derivative Gain Loss On Derivative Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Derivative, Gain (Loss) on Derivative, Net | Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. |
| Stock Issued During Period Value Exerciseof Prefunded Warrants Into Shares | 0001641172-25-010384 | 1 | 0 | monetary | D | C | Exercise of prefunded warrants into shares | Exercise of prefunded warrants into shares. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Stock Issued During Period Shares Exerciseof Prefunded Warrants Into Shares | 0001641172-25-010384 | 1 | 0 | monetary | D | C | Exercise of prefunded warrants into shares, shares | Exercise of prefunded warrants into shares ,shares. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-010384 | 2 | 2 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001641172-25-010384 | 2 | 3 | BS | 0 | H | Other Assets Current | us-gaap/2024 | Other current assets | 0 |
| 0001641172-25-010384 | 2 | 4 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001641172-25-010384 | 2 | 5 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use asset, net | 0 |
| 0001641172-25-010384 | 2 | 6 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001641172-25-010384 | 2 | 7 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
| 0001641172-25-010384 | 2 | 8 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001641172-25-010384 | 2 | 11 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001641172-25-010384 | 2 | 12 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liability, current | 0 |
| 0001641172-25-010384 | 2 | 13 | BS | 0 | H | Convertible Notes Payable Current | us-gaap/2024 | Convertible promissory notes | 0 |
| 0001641172-25-010384 | 2 | 14 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Other current liabilities | 0 |
| 0001641172-25-010384 | 2 | 15 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001641172-25-010384 | 2 | 17 | BS | 0 | H | Derivative Liabilities Noncurrent | us-gaap/2024 | Derivative financial liabilities (Note 2F and Note 3B) | 0 |
| 0001641172-25-010384 | 2 | 18 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, non-current | 0 |
| 0001641172-25-010384 | 2 | 19 | BS | 0 | H | Long Term Loans Payable | us-gaap/2024 | Loans from stockholders | 0 |
| 0001641172-25-010384 | 2 | 20 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001641172-25-010384 | 2 | 22 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common Stock of $0.001 par value (Common Stock) 250,000,000 and 100,000,000 shares authorized as of March 31, 2025 and December 31, 2024, respectively; 25,585,853 and 791,609 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001641172-25-010384 | 2 | 23 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001641172-25-010384 | 2 | 24 | BS | 0 | H | Receipts On Account Of Shares | 0001641172-25-010384 | Receipts on account of shares | 0 |
| 0001641172-25-010384 | 2 | 25 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income | 0 |
| 0001641172-25-010384 | 2 | 26 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001641172-25-010384 | 2 | 27 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity (deficit) | 0 |
| 0001641172-25-010384 | 2 | 28 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT) | 0 |
| 0001641172-25-010384 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-010384 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-010384 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-010384 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-010384 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001641172-25-010384 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001641172-25-010384 | 4 | 4 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2024 | Selling and marketing expenses | 0 |
| 0001641172-25-010384 | 4 | 5 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001641172-25-010384 | 4 | 6 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 1 |
| 0001641172-25-010384 | 4 | 8 | IS | 0 | H | Derivative Gain Loss On Derivative Net | us-gaap/2024 | Change in fair value of derivative liabilities | 1 |
| 0001641172-25-010384 | 4 | 9 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other (income) expense, net | 1 |
| 0001641172-25-010384 | 4 | 10 | IS | 0 | H | Finance Expense Income Net | 0001641172-25-010384 | Finance expenses (income), net | 1 |
| 0001641172-25-010384 | 4 | 11 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net Loss | 1 |
| 0001641172-25-010384 | 4 | 13 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation adjustment | 1 |
| 0001641172-25-010384 | 4 | 14 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss for the period | 1 |
| 0001641172-25-010384 | 4 | 15 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic net loss per common stock | 0 |
| 0001641172-25-010384 | 4 | 16 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted net loss per common stock | 0 |
| 0001641172-25-010384 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of common stock outstanding used in computing basic loss per common stock | 0 |
| 0001641172-25-010384 | 4 | 18 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of common stock outstanding used in computing diluted loss per common stock | 0 |
| 0001641172-25-010384 | 5 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-010384 | 5 | 11 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-010384 | 5 | 12 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Loss for the period | 0 |
| 0001641172-25-010384 | 5 | 13 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Other comprehensive income | 0 |
| 0001641172-25-010384 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-010384 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | Issuance of restricted shares as compensation towards directors | 0 |
| 0001641172-25-010384 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | Issuance of restricted shares as compensation towards directors, shares | 0 |
| 0001641172-25-010384 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Payment For Achievement Of Milestone | 0001641172-25-010384 | Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 4B) | 0 |
| 0001641172-25-010384 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Payment For Achievement Of Milestone | 0001641172-25-010384 | Issuance of restricted shares as payment for achievement of milestone pursuant to purchase agreement (Note 5B), shares | 0 |
| 0001641172-25-010384 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Value Exerciseof Prefunded Warrants Into Shares | 0001641172-25-010384 | Exercise of prefunded warrants into shares | 0 |
| 0001641172-25-010384 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Shares Exerciseof Prefunded Warrants Into Shares | 0001641172-25-010384 | Exercise of prefunded warrants into shares, shares | 0 |
| 0001641172-25-010384 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | Exchange of warrants into shares | 0 |
| 0001641172-25-010384 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | Exchange of warrants into shares, shares | 0 |
| 0001641172-25-010384 | 5 | 23 | EQ | 0 | H | Stock To Be Issued During Period Value Restricted Stock Award Gross | 0001641172-25-010384 | Restricted shares to be issued as compensation towards directors | 0 |
| 0001641172-25-010384 | 5 | 24 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock upon completion of public offering, net of offering expenses | 0 |
| 0001641172-25-010384 | 5 | 25 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock upon completion of public offering, net of offering expenses, shares | 0 |
| 0001641172-25-010384 | 5 | 26 | EQ | 0 | H | Stock Issued During Period Value Exercise Of Warrants Into Common Stock | 0001641172-25-010384 | Cashless exercise of warrants into common stock | 0 |
| 0001641172-25-010384 | 5 | 27 | EQ | 0 | H | Stock Issued During Period Shares Exercise Of Warrants Into Common Stock | 0001641172-25-010384 | Cashless exercise of warrants into common stock,shares | 0 |
| 0001641172-25-010384 | 5 | 28 | EQ | 0 | H | Adjustments To Additional Paid In Capital Stock Split | us-gaap/2024 | Stock split adjustment | 0 |
| 0001641172-25-010384 | 5 | 29 | EQ | 0 | H | Adjustments To Additional Paid In Capital Stock Split Shares | 0001641172-25-010384 | Stock split adjustment, shares | 0 |
| 0001641172-25-010384 | 5 | 30 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-010384 | 5 | 31 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-010384 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Loss for the period | 0 |
| 0001641172-25-010384 | 6 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001641172-25-010384 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-010384 | 6 | 6 | CF | 0 | H | Issuance Of Restricted Shares As Compensation To Board Of Directors | 0001641172-25-010384 | Issuance of restricted shares as compensation towards directors | 0 |
| 0001641172-25-010384 | 6 | 7 | CF | 0 | H | Derivative Gain Loss On Derivative Net | us-gaap/2024 | Change in fair value of derivative liability (Note 2H) | 1 |
| 0001641172-25-010384 | 6 | 8 | CF | 0 | H | Amortization Of Financing Costs And Discounts | us-gaap/2024 | Amortization of debt discount and interest expense related to promissory notes | 0 |
| 0001641172-25-010384 | 6 | 9 | CF | 0 | H | Linkage Difference On Principal Of Loans From Stockholders | 0001641172-25-010384 | Linkage difference on principal of loans from stockholders | 0 |
| 0001641172-25-010384 | 6 | 11 | CF | 0 | H | Increase Decrease In Other Current Assets | us-gaap/2024 | Increase in other current assets | 1 |
| 0001641172-25-010384 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Increase in accounts payable | 0 |
| 0001641172-25-010384 | 6 | 13 | CF | 0 | H | Increase Decrease In Other Current Liabilities | us-gaap/2024 | Increase (Decrease) in other current liabilities | 0 |
| 0001641172-25-010384 | 6 | 14 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001641172-25-010384 | 6 | 16 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchase of property and equipment | 1 |
| 0001641172-25-010384 | 6 | 17 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001641172-25-010384 | 6 | 19 | CF | 0 | H | Net Proceeds Received From Underwritten Public Offering | 0001641172-25-010384 | Net proceeds from underwritten U.S. public offerings (Note 3A) | 0 |
| 0001641172-25-010384 | 6 | 20 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001641172-25-010384 | 6 | 21 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Effect of exchange rate changes on cash and cash equivalents, and restricted cash | 0 |
| 0001641172-25-010384 | 6 | 22 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Change in cash and cash equivalents, and restricted cash | 0 |
| 0001641172-25-010384 | 6 | 23 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents, and restricted cash at beginning of the period | 0 |
| 0001641172-25-010384 | 6 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents, and restricted cash, end of period | 0 |
| 0001641172-25-010384 | 6 | 27 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Interest | 0 |
| 0001641172-25-010384 | 6 | 29 | CF | 0 | H | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | Recognition of right for usage asset against a lease liability | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |